Background-Several trials have demonstrated improved survival with implantable cardioverter-defibrillator (ICD) therapy.
I mplantable cardioverter-defibrillators (ICDs) have been demonstrated to improve survival in both secondary prevention 1,2 and primary prevention [3] [4] [5] populations. The incidence of ICD implantations was estimated in 2007 to be >230 000 in the United States and >87 000 in Europe. 6 Implantation rates have increased since then. The ICD extends life, but the treatment is not free from complications. ICD shocks can cause pain and anxiety. 7, 8 
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ICDs are implanted to prevent sudden death, but the patient may die of other causes. The cause and nature of death in the ICD population have been investigated insufficiently, and postmortem interrogation of the devices has not been accomplished systematically. Previous studies have shown that 20% to 60% of patients with ICDs who were dying had ventricular arrhythmias before death, but the incidence of shocks is not well documented. 9, 10 To the best of our knowledge, there have been only a few case studies and no comprehensive reviews published regarding the incidence of shocks in patients at end of life in the ICD population.
Furthermore, the incidence of ICD malfunction is not known because of the absence of systematic postmortem assessment of these devices. The Heart Rhythm Society has published a statement supporting return of devices to manufacturers. 11 Despite this, the return of explanted devices remains very low. 12, 13 The aim of the present study was to analyze explanted ICDs from deceased patients to assess the incidence of ventricular tachyarrhythmias, the occurrence of shocks, and possible device malfunction before death.
Methods

Study Group and Device Collection
All participating pathology departments were asked to take part in the present study before device enrolment and agreed to return all ICDs that were explanted during the inclusion period to the study center. Explantation of devices (pacemaker or ICD) after death is mandatory in Sweden and was not done as part of the study protocol. The study prospectively enrolled 130 ICD devices nationally. All ICDs were sent to the study center by the pathology departments of the 26 participating hospitals. In 5 devices, the data were not accessible, and the devices were, after analysis by the manufacturer, excluded (Figure 1) .
The study population's demographic data were obtained from patients' medical records, the Swedish ICD and Pacemaker Register, and the National Board of Health and Welfare. If performed, the reports of autopsies were also retrieved, and death certificates were obtained from the Swedish Tax Agency. Time of death for patients who died in the hospital was established from medical notes of both
Analysis of Arrhythmias
All ICDs were interrogated, and all available intracardiac electrograms from the 24 hours before death were retrieved. Three investigators, 2 of them blinded to patients' medical records and arrhythmic history, performed the review and analysis of the electrograms independently. If the investigators disagreed on the origin (ie, ventricular or supraventricular) of the arrhythmia, a fourth blinded investigator proceeded with the analysis, and a consensus decision was taken. If 3 of 4 investigators identified the arrhythmia similarly, agreement was considered to have been achieved.
The arrhythmias were divided into the final 24 hours and the last hour before time of death. The incidence of ventricular tachyarrhythmia (ventricular tachycardia [VT] or ventricular fibrillation [VF]) and shock treatment was recorded. Information on drugs prescribed within the previous 6 months, last available echocardiogram, and ICD implantation data were collected. Medical records from the final 24 hours were obtained for all patients who died in the hospital, along with the notes from the last visit to the ICD clinic. The classification described by Lang et al 14 was used for the ejection fraction measured by the echocardiogram (normal, ≥55%; mildly reduced, 45% to 54%; moderately reduced, 30% to 44%; and severely reduced, <30%).
Presence of VT/VF within 1 hour of death was classified as arrhythmia at death. The arrhythmias were then analyzed and classified as the primary cause of death or not. Arrhythmic classification was made with regard to the programming of the device. If the rate of the arrhythmia fell into any of the programmed VT/VF zones, it was analyzed as VT/VF. The definition of an electrical storm used was the occurrence of ≥3 episodes of VT/VF within a 24-hour period. 15 The device presents the arrhythmia as an electrogram, but it has a set storage capacity. When there are numerous arrhythmias, the possibility of having them all presented as electrograms is not an option. The ICD saves the most recent events as electrograms and will present the remainder in a logbook, with data regarding diagnosis, time, rate, and therapy given. Electrograms that were missing because of overfilled storage capacity were categorized as VT/VF only if the reviewed and available arrhythmias were diagnosed correctly as VT/ VF by the ICD.
To classify the ICD as successful in arrhythmia termination, the rhythm had to be either spontaneous sensed or pacemaker-driven beats in a frequency below the lowest VT zone. Additionally, the morphology of the rhythm after treatment had to be similar to that of normal beats. Device function was classified as correct or incorrect depending on success in diagnosis and treatment given, as well as when there was any evidence of lead malfunction. The arrhythmia was classified as oversensing if there was double counting of wide QRS.
Shock treatment within 24 hours of death was classified as shock at the end of life. Shocks were classified as appropriate or inappropriate, for example, shocks for atrial fibrillation or supraventricular tachycardia. In addition to the occurrence of any shocks, we assessed the number of shocks received during the last 24 hours of life. 
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Death Classification
Death was classified by a modified version of the classification scheme of Epstein et al. 16 Two investigators reviewed all deaths. The primary causes were divided into categories of cardiac and noncardiac death. Death was classified as sudden if it occurred within 1 hour of the onset of new symptoms. 17 If time of death could not be stated and death was unwitnessed, the temporal cause was classified as unknown. If the arrhythmia detection was programmed "on" or the patient was undergoing continuous telemetry, the death was classified as monitored. System-related causes of death were cases in which evidence of malfunction, such as malprogramming, lead malfunction, or a procedure-related (perioperative or postoperative) complication, was found and regarded as the cause of death. In a few cases, there was some undersensing of terminal arrhythmias; this was not regarded as a system-related cause of death if previous arrhythmias were detected correctly and treatment was not withheld because of this.
Statistical Analysis
Descriptive statistics are presented as means and standard deviations for numeric variables, percentages for categorical variables, or confidence interval of proportions. The normal approximation to the binomial distribution was used. This is valid because if np=10 and n(1−p)=10, then p can be assumed to have an approximately normal distribution, where n is the sample size and p is the proportion. 18 Taking the prevalence of ventricular arrhythmia as 50% (to obtain the maximum sample size), the margin of error as 10%, and the confidence interval as 95%, a sample size of 96 patients was required for the study. 19 Statistical analysis was performed with SPSS software version 20.
The ICDs were assumed to be sensitive to electromagnetic interference during both explantation and transportation. Electromagnetic interference could be interpreted as arrhythmia and could overwhelm the counters. Recorded electromagnetic interference would render postmortem analysis invalid, which prompted the decision to include 34 additional patients to compensate for the potential dropout on these grounds.
Ethics
The study was approved by the regional ethics committee (2008/1527-31/4).
Results
Study Group
The baseline characteristics of the study group are presented in Table 1 . All patients died in the years 2003 to 2010. ICD implantations were performed between 1998 and 2010, and patients' ICDs had been implanted for a mean duration of 2.6±2 years. Because of unavailable data, 5 devices were excluded and sent back to the manufacturer for analysis. In all 5 cases, the manufacturers concluded that the devices had entered their end-of-life stage, that is, battery depletion. It was possible to extract some basic data to determine the date when the ICD reached its end of life, and in all devices, these dates were after the patient's date of death. Descriptive data are based on the remaining 125 devices ( Figure 1 ).
Secondary prevention was the major indication (82%) for the initial ICD implantation. Of the 125 ICDs, 35% were biventricular (CRT-D) devices with an active left ventricular lead implanted. The distribution of manufacturers represented in the present study was similar to that for implanted devices in Sweden between 2008 and 2011. 20 The majority of the patients (80%) were in a hospital or care facility at the time of death ( Figure 2 ). More than half of the 125 patients (52%) had a do-not-resuscitate (DNR) order that was active in their medical records.
Arrhythmia Analysis
In some devices, disabling shock therapy also turns off the detection of arrhythmias; in other devices, shock therapy can be turned off while arrhythmia detection remains active. The timespan when therapy was turned off differed greatly, from months before death to as close as 30 minutes before death. Among the 125 devices, there were 25 that had been programmed to detection "off" 24 hours before the patient died, and therefore, there was no further possibility of detecting an arrhythmia. Results regarding VT/VF at 24 hours before death are therefore based on a study population of 100 patients (Figure 1 ). There were 38 patients with VT/VF during the final 24 hours (38%; 95% confidence interval, 29%-48%), and 31 (31%) experienced ≥1 shock.
There were 24 patients (24%) who had an arrhythmic storm during their last 24 hours (Figure 3 ). There was a great variability of events, with a mean of 13±12 events per patient. Of the patients with an arrhythmic storm, 19 (79%) received shock treatment. A DNR order was found for 10 patients (42%), and 6 of these patients (60%) received shocks, with a mean of 5.6±6.5 shocks per patient. Patients without a DNR order had a mean of 13.6±14.4 shocks.
During the last 1 hour, arrhythmia detection was programmed "on" in 94 patients. Of these patients, 33 (35%; 95% confidence interval, 25%-46%) had VT/VF and 1 (1%) had a bradyarrhythmia. Of the 87 patients with shock programmed "on" at 1 hour before death, 27 (31%) experienced shock treatment. Of the 33 patients who had VT/VF, the time of death was witnessed in 21 cases (64%).
In 97 patients, shock therapy was programmed "on" at 24 hours before death. The probability of experiencing a shock treatment 24 hours before death was 32% (95% confidence interval, 26%-41%). Of the patients who received shocks, 14 (45%) received 1 to 2 shocks and 17 (55%) received ≥3 shocks. There were 10 patients (32%) who each experienced >10 shocks. Inappropriate therapy was given to 4 patients (13%) because of supraventricular tachycardia or oversensing.
Of the 65 patients (52%) with a DNR order, 42 (65%) had shock therapy "on" at 24 hours, and 33 (51%) still had the ICD activated 1 hour before death. Ventricular tachyarrhythmias (VT/VF) occurred in 13 of those 33 (39%), and 10 of the 42 patients with shock therapy "on" at 24 hours (24%) received shock treatment during the final 24 hours, all after the DNR order was written. The number of shocks for each individual is presented in Table 2 .
For 19 of the 31 patients who received shock treatment during the final 24 hours (61%), no evidence was found in the medical notes to suggest that the patient, next of kin, or caregivers had recognized that shock therapy was given. In 1 case (3%), there was a record of patient recognition of shock treatment, and in 5 other cases (16%), the shocks were recognized by caregivers. In an additional 6 patients (19%), caregivers had made notes that patients had shown signs of pain or stress during the last hours.
There were 4 system-related deaths (3%). A possible device malfunction was caused by undersensed VF in 3 cases. Of those 3 cases, 1 ICD had no VT/VF in the device diagnostics, but VF was identified on telemetry; in the other 2 cases, the device identified the arrhythmia, but no treatment was given because the VF was undersensed, and both patients died as a consequence. A possible lead failure was identified in 1 case. With a sudden development of loss of capture and failing attempts to increase pacing output, the patient died a bradycardic death caused by prior His bundle ablation. There were an additional 9 cases of intermittent undersensing (7%), which was not regarded as the cause of death because of the natural change in amplitude in untreatable VF in a dying patient.
In 2 devices (2%), no electrograms were available because of noise that overwhelmed the counters. The arrhythmias were classified by the ICD as VT/VF and presented in the logbook. In 1 of these devices, data from the histogram were available, in which the ventricular frequency correlated with a ventricular tachyarrhythmia. In the other case, the device was sent to the manufacturer for analysis, which showed VT/VF with shock treatment at the same time as death, but there was no available electrogram. The investigators chose to classify both arrhythmias as VT/VF treated appropriately with a shock because of the correlation in timing of the arrhythmia and time of death and no signs of malfunction of the ICDs.
Death Classification
Arrhythmic death was the primary cause of death in 16 of the 125 patients (13%). Cardiac death attributable to heart failure (37%) was the most common cause of death (Table 3) . The results of the death classifications made by the investigators were similar to the mortality data received from the National Board of Health and Welfare with regard to the classification between cardiac death and noncardiac death. In 29 patients (23%), the cause of death was classified as sudden death. Arrhythmic cause of death was found in 16 (55%) of these sudden deaths; shock treatments were delivered in 14, and 1 had an aborted shock.
Discussion
The most important finding of the present study was that ICD patients often died in the hospital, and one third had ventricular tachyarrhythmia events with shocks close to death. More than half (52%) of the patients had a DNR order. Despite this, 51% of the patients with a DNR order still had shock therapy programmed "on" at 1 hour before death, which allowed unnecessary and possibly painful shocks to be administered to the dying patient.
Study Group
The patients studied had a high rate of comorbidity, which is consistent with the high number of patients who had DNR orders. A comparison of the demographics of the present study with others is difficult. The characteristics of patients in the present study were based on patient diagnosis close to death, and in other studies, patient characteristics are usually established before or at the time of ICD implantation. 1, 9, 10, 21 To the best of our knowledge, no comparable study is available.
Most of the patients (80%) in the present study died in a setting in which they had 24-hour access to healthcare assistance, and the majority died in an acute hospital setting (71%). In most cases (66%), they had been admitted to an internal medicine department (including the cardiology department).
A high percentage (82%) of the study patients received their ICD for secondary prevention. The ICD devices studied were implanted between 1998 and 2010. Many of the patients received their primary ICD even earlier than this. Secondary prevention was by far the most common indication for ICD treatment in Europe at the time; primary prevention received a Class I, Level of Evidence A indication for the first time in 2006. [22] [23] [24] Today's higher implantation rates for primary prevention may influence the results, which may not be extrapolated to the present-day ICD population. The study population, therefore, could be more prone to tachyarrhythmias than if the study were to be performed today.
Arrhythmia Analysis
More than one third (35%) of the patients had VT/VF in the last hour of life; however, patients died of underlying cardiac disease rather than arrhythmic death. The incidence of VT/VF before death in the present study confirms results from previous studies. 9, 10 Just over one fourth (26%) of the patients had an arrhythmic storm during their final 24 hours before death. Death was in most cases attributable to underlying organic causes that rendered the patient liable to have multiple arrhythmic events and even an arrhythmic storm while dying of the known underlying cause. Patients showed great variability in numbers of shocks, with a range from 1 to 53. Of the patients with arrhythmic storms, there were 10 (42%) who had a DNR order. All 10 had shock therapy programmed "on" at 24 hours. The number of shocks delivered could easily have been higher, because in 2 patients with an active DNR order, therapy was not delivered because the ventricular arrhythmia was undersensed; in addition, 1 patient had an aborted shock, and 3 patients had ventricular arrhythmias that fell within their monitoring zone rather than a treatment zone. In 5 of the patients, shock therapy was turned off at some time during their final 24 hours, in 1 case as close as 30 minutes before death.
Many of the 31 patients who received shock therapy were in the hospital. This could be either because this was a population with a high morbidity that required hospitalization or because the patients had multiple shocks before dying that warranted medical attendance. The results are similar to those of Goldstein et al, 25 published in 2004, in which the next of kin of the dying patients reported shock treatment in 27% of the patients in the final month; of these, 30% had shock treatment immediately before death. The present finding highlights the need to address the problem of ICD shocks during end-oflife care. The patient is still at risk of unnecessary, possibly painful shocks despite progressive illness and imminent death. Little progress has been made despite published consensus statements in 2010 from both the Heart Rhythm Society and the European Heart Rhythm Association that highlighted the importance of discussing device deactivation with patients and their families. 26, 27 There were a small number of patients (2%) who had a very high number of shocks throughout the last week before death. They could not communicate because of stroke but did show signs of pain according to the medical notes.
When we reviewed the medical notes, a notation of patient distress or pain before death was found for 19% of the 31 patients who received shock treatment. This pain could have several causes but may be attributable to shock treatment. A notation in which the caregivers identified shock treatment was found in 16%. In the majority of the patients who received shock treatment (61%), nothing was found in the medical notes with regard to recognition of shock treatment. One patient had a notation of heavy muscle spasm, correlated in time with when the shocks were given. It was not identified as being related to shocks by the caregiver but was treated with an injection of diazepam. Exactly how many of the 31 patients actually experienced great pain during shock treatment remains unknown.
A possible malfunction of the ICD was found in 4 cases. One pacemaker-dependent patient died unexpectedly after possible lead failure. A sudden loss of capture occurred, and pacing output was increased promptly but failed to capture; an attempt with a temporary lead was not successful. The patient had been in the hospital for 2 months because of problematic VT and was being treated with VT ablation and antiarrhythmic drugs. There could be another possible cause of death in this patient; however, the possibility of lead failure could not be excluded. In the remaining 3 cases, a possible device malfunction was identified that was attributable to undersensing of VF, all classified by the investigators as the actual cause of death. Two of these patients received palliative care because of malignancy before the arrhythmic event. The possible malfunction had little impact on the clinical outcome, because the patient's death was imminent in both cases. However, the ICDs were not capable of sensing and treating a malignant arrhythmia, which is the primary task of the device, and these were therefore classified as a possible malfunction. In the third remaining case, the patient died a sudden unexpected death attributable to undersensed VT/VF, registered by telemetry but not in the device. The patient was externally defibrillated successfully at first but died in the intensive care unit within 1 hour. In 6 patients, there was intermittent undersensing that caused a delay in treatment given. There is always a possibility of undersensing of events. New sensing algorithms in modern ICDs minimize this problem.
The concern regarding ICDs sensitivity to electromagnetic interference was shown to be overestimated. Only 2 devices had noise that overwhelmed the counters after death. In addition, no case of double counting of slow, wide QRS was found.
Death Classification
Death is always associated with an arrhythmic event in the sense that the heart stops, and there will ultimately be asystole. Classification of death is difficult because of the lack of validated data surrounding a person's death. The classification is subjective and associated with possible error. [28] [29] [30] Autopsies are usually only available in a low proportion of cases, which was also true for the present study (11%).
Just over one fifth of the patients (23%) died of sudden death, and the majority of these deaths (55%) were caused by VT/VF. The most common causes of noncardiac sudden death were infection and vascular events (aneurysm, embolism). Almost half of the 29 patients who died suddenly (48%) received shock treatment, and 1 patient had an aborted shock.
ICD trials in general have reported inappropriate therapies in 10% to 24% of the ICD population. 31 The incidence of inappropriate shocks at the end of life is not well known. In the present study, 4% of the patients received inappropriate shocks during their last 24 hours because of atrial arrhythmias and oversensing. Comparison of inappropriate shocks between the present study and studies reviewed by Germano et al 31 may be difficult because of the different period of time (the final 24 hours of a patient's life compared with incidence of shocks during the entire duration of the ICD trials reviewed by Germano et al 31 ). Many of the patients had a DNR code status; however, the device was deactivated in only half of these patients at the time of their death. Leaving the device active in a DNR patient confers a risk of unnecessary shock treatment that is not in line with the patient's goals of care. The decision about deactivation is not an easy process. Healthcare professionals have to ensure that the dying process includes as little pain, anxiety, and distress for the patient as possible and must make a great effort to identify the key medical issues, which include unnecessary ICD therapy and possible prolongation of the process of death.
Study Limitations
The ICD's internal time is not always accurate. Some of the devices interact with the programmer used at the time of interrogation. The time stated on the electrogram can differ if interrogated at different times. Also, there is an issue of summertime/wintertime in both the device and programmer, which may cause a discrepancy with respect to actual time by ±1 hour. In the present study, we regarded VT/VF within 1 hour of time of death as arrhythmia at death. Sudden cardiac death is generally classified as death within 1 hour of symptom onset. 17 Classification of death is difficult and often subjective. There are difficulties regarding determining the exact timing of onset of symptoms when chronic symptoms are present. Classification is dependent on the quality of available data. Time of death is not accurate in all cases when death is unwitnessed. In 61% of the patients, death was witnessed and the timing accurate. In other cases, an estimation of the time of death was made by the investigators depending on where the patient died, that is, in a hospital or alone at home.
During the present study, there was a change in accepted ICD indications to include primary prevention. As a result, the patient population captured in the present study, which was predominantly a secondary prevention population, may not be representative of current ICD recipients, many of whom are primary prevention patients. This inevitably affects the results in such a way that the present study population may have a higher risk of recurrent ventricular tachyarrhythmias than if the study were performed today.
Conclusions
Most ICD patients died in the hospital; more than one third of the patients had a ventricular tachyarrhythmia within the last hour of life. An arrhythmic cause of death was found in 13%. Cardiac death was the primary cause and heart failure the specific cause of death in the majority of the cases. Devices remained active in more than half of the patients with a DNR order; almost one fourth of these patients received ≥1 shock in the last hours of life.
CLINICAL PERSPECTIvE
The cause and nature of death in the growing population treated with implantable defibrillators have been insufficiently investigated. An increased knowledge of the incidence of ventricular arrhythmia and shock treatment at the end of life for patients with an implantable defibrillator may lead to improved care and a lower incidence of unnecessary and painful shocks for patients close to death. This study shows that such patients often die in the hospital of late-stage heart failure. More than one third of patients have ventricular arrhythmia 1 hour before death, and almost one fourth experience shock treatment during the last 24 hours. The majority of all patients in the present study had a do-not-resuscitate order but still had shock therapy programmed "on," which exposed these patients to the risk of painful shocks. It is important for healthcare providers to take action in deciding to deactivate the implantable defibrillator in terminally ill patients.
